Fig. 5.

Treatment algorithm for management of STEMI during COVID-19.

*COVID-19 person under investigation: Any patient with fever or cough or shortness of breath with an elevated biomarker (C-reactive protein or lactate dehydrogenase) but a negative rapid COVID-19 test.

** Rule out ACS mimics before administering thrombolysis such as myocarditis, takotsubo cardiomyopathy, or pericarditis by careful evaluation of EKG and point-of-care ultrasound.

STEMI - ST-segment elevation myocardial infarction.

PCI - Percutaneous coronary intervention. PUI - Patient under investigation.